Skip to main content
Erschienen in: International Urogynecology Journal 1/2021

25.07.2020 | Original Article

Incontinence outcomes after “second primary” compared to repeat midurethral sling for recurrent and persistent stress urinary incontinence

verfasst von: Anna K. Melnikoff, Isuzu Meyer, Kimberly D. Martin, Holly E. Richter

Erschienen in: International Urogynecology Journal | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The current study aims to assess the continence rate of a “second primary” midurethral sling (MUS) in women with recurrent/persistent stress urinary incontinence (SUI) after sling excision compared to a historical cohort who underwent a repeat MUS.

Methods

A retrospective cohort study of women who underwent excision of a primary MUS and placement of a “second primary” MUS from 2009 to 2016 compared to a historical cohort who underwent a repeat MUS from 2006 to 2009. The primary outcome was continence rate, defined as “not at all” or “somewhat” to Urogenital Distress Inventory (UDI-6) SUI subscale questions. Secondary outcomes included assessment of symptom severity (UDI-6), symptom-specific quality of life, Incontinence Impact Questionnaire (IIQ-7), Medical and Epidemiologic Aspects of Aging (MESA), and Patient Global Impression of Improvement (PGI-I).

Results

Survey responses were available for 23/64 (36%) in the “second primary” MUS group versus 88/135 (65%) in the historical cohort. Mean follow-up in months, second primary: 41.8 ± 26.1 versus repeat: 36.2 ± 14.1, p = 0.16 and age (years): 56.4 ± 10.7 versus 59.8 ± 10.8, p = 0.19. Continence rates were 48% in “second primary” versus 56% in the repeat group (p = 0.50). Both groups had significant improvement in questionnaire scores postoperatively with no intergroup differences. Multivariable analysis demonstrated that odds of success did not differ between groups (adjusted odds ratio: 0.73, 95% confidence interval: 0.27–1.99).

Conclusions

In women with recurrent/persistent SUI, repeat and “second primary” MUS procedures demonstrate similar success outcomes and improvement in UI symptom distress and QOL. Continued research is needed for this increasingly important clinical question.
Literatur
1.
Zurück zum Zitat ACOG. Practice bulletin no. 155: urinary incontinence in women. Obstet Gynecol. 2015;126(5):e66–81.CrossRef ACOG. Practice bulletin no. 155: urinary incontinence in women. Obstet Gynecol. 2015;126(5):e66–81.CrossRef
2.
Zurück zum Zitat Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol. 2004;6(Suppl 3):S3–9.PubMedPubMedCentral Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol. 2004;6(Suppl 3):S3–9.PubMedPubMedCentral
3.
Zurück zum Zitat Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362(22):2066–76.CrossRef Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362(22):2066–76.CrossRef
4.
Zurück zum Zitat Liapis A, Bakas P, Creatsas G. Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Eur Urol. 2009;55(6):1450–5.CrossRef Liapis A, Bakas P, Creatsas G. Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Eur Urol. 2009;55(6):1450–5.CrossRef
5.
Zurück zum Zitat Jonsson Funk M, Siddiqui NY, Kawasaki A, et al. Long-term outcomes after stress urinary incontinence surgery. Obstet Gynecol. 2012;120(1):83–90.CrossRef Jonsson Funk M, Siddiqui NY, Kawasaki A, et al. Long-term outcomes after stress urinary incontinence surgery. Obstet Gynecol. 2012;120(1):83–90.CrossRef
6.
Zurück zum Zitat Smith AL, Karp DR, Aguilar VC, et al. Repeat versus primary slings in patients with intrinsic sphincter deficiency. Int Urogynecol J. 2013;24(6):963–8.CrossRef Smith AL, Karp DR, Aguilar VC, et al. Repeat versus primary slings in patients with intrinsic sphincter deficiency. Int Urogynecol J. 2013;24(6):963–8.CrossRef
7.
Zurück zum Zitat Stav K, Dwyer PL, Rosamilia A, et al. Risk factors of treatment failure of midurethral sling procedures for women with urinary stress incontinence. Int Urogynecol J. 2010;21(2):149–55.CrossRef Stav K, Dwyer PL, Rosamilia A, et al. Risk factors of treatment failure of midurethral sling procedures for women with urinary stress incontinence. Int Urogynecol J. 2010;21(2):149–55.CrossRef
8.
Zurück zum Zitat Parden AM, Gleason JL, Jauk V, et al. Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures. Obstet Gynecol. 2013;121(2):273–8.CrossRef Parden AM, Gleason JL, Jauk V, et al. Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures. Obstet Gynecol. 2013;121(2):273–8.CrossRef
9.
Zurück zum Zitat Kim TH, You HW, Ryu DS, et al. Surgical outcome of a repeat midurethral sling procedure after failure of a first procedure. Int Urogynecol J. 2015;26(12):1759–66.CrossRef Kim TH, You HW, Ryu DS, et al. Surgical outcome of a repeat midurethral sling procedure after failure of a first procedure. Int Urogynecol J. 2015;26(12):1759–66.CrossRef
10.
Zurück zum Zitat Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Continence program for women research group. Neurourol Urodyn. 1995;14(2):131–9.CrossRef Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Continence program for women research group. Neurourol Urodyn. 1995;14(2):131–9.CrossRef
11.
Zurück zum Zitat Shumaker SA, Wyman JF, Uebersaw JS, et al. Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. Continence program in women (CPW) research group. Qual Life Res. 1994;3(5):291–306.CrossRef Shumaker SA, Wyman JF, Uebersaw JS, et al. Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. Continence program in women (CPW) research group. Qual Life Res. 1994;3(5):291–306.CrossRef
12.
Zurück zum Zitat Herzog AR, Diokno AC, Brown MD, et al. Two-year incidence, remission, and change patterns of urinary incontinence in noninstitutionalized older adults. J Gerontol. 1990;45(2):M67–74.CrossRef Herzog AR, Diokno AC, Brown MD, et al. Two-year incidence, remission, and change patterns of urinary incontinence in noninstitutionalized older adults. J Gerontol. 1990;45(2):M67–74.CrossRef
13.
Zurück zum Zitat Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003;189(1):98–101.CrossRef Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003;189(1):98–101.CrossRef
14.
Zurück zum Zitat Burgio KL, Goode PS, Richter HE, et al. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings. Neurourol Urodyn. 2006;25(5):411–7.CrossRef Burgio KL, Goode PS, Richter HE, et al. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings. Neurourol Urodyn. 2006;25(5):411–7.CrossRef
15.
Zurück zum Zitat Kociszewski J, Majkusiak W, Pomian A, et al. The Outcome of Repeated Mid Urethral Sling in SUI Treatment after Vaginal Excisions of Primary Failed Sling: Preliminary Study. Biomed Res Int. 2016;2016:1242061. Kociszewski J, Majkusiak W, Pomian A, et al. The Outcome of Repeated Mid Urethral Sling in SUI Treatment after Vaginal Excisions of Primary Failed Sling: Preliminary Study. Biomed Res Int. 2016;2016:1242061.
16.
Zurück zum Zitat Verbrugghe A, De Ridder D, Van der Aa F. A repeat mid-urethral sling as valuable treatment for persistent or recurrent stress urinary incontinence. Int Urogynecol J. 2013;24(6):999–1004. Verbrugghe A, De Ridder D, Van der Aa F. A repeat mid-urethral sling as valuable treatment for persistent or recurrent stress urinary incontinence. Int Urogynecol J. 2013;24(6):999–1004.
17.
Zurück zum Zitat Steele SE, Hill AJ, Unger CA. Concurrent midurethral sling excision or lysis at the time of repeat sling for treatment of recurrent or persistent stress urinary incontinence. Int Urogynecol J. 2018;29(2):285–290. Steele SE, Hill AJ, Unger CA. Concurrent midurethral sling excision or lysis at the time of repeat sling for treatment of recurrent or persistent stress urinary incontinence. Int Urogynecol J. 2018;29(2):285–290.
Metadaten
Titel
Incontinence outcomes after “second primary” compared to repeat midurethral sling for recurrent and persistent stress urinary incontinence
verfasst von
Anna K. Melnikoff
Isuzu Meyer
Kimberly D. Martin
Holly E. Richter
Publikationsdatum
25.07.2020
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 1/2021
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-020-04447-6

Weitere Artikel der Ausgabe 1/2021

International Urogynecology Journal 1/2021 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.